Goldenwell Biotech (GWLL) Other Non-Current Liabilities (2022 - 2025)
Goldenwell Biotech's Other Non-Current Liabilities history spans 4 years, with the latest figure at $189250.0 for Q3 2025.
- For Q3 2025, Other Non-Current Liabilities fell 11.91% year-over-year to $189250.0; the TTM value through Sep 2025 reached $189250.0, down 11.91%, while the annual FY2024 figure was $189250.0, 170.36% up from the prior year.
- Other Non-Current Liabilities reached $189250.0 in Q3 2025 per GWLL's latest filing, roughly flat from $189250.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $214838.0 in Q2 2024 to a low of $20000.0 in Q4 2022.
- Average Other Non-Current Liabilities over 4 years is $135188.7, with a median of $177419.0 recorded in 2024.
- Peak YoY movement for Other Non-Current Liabilities: surged 329.68% in 2024, then dropped 11.91% in 2025.
- A 4-year view of Other Non-Current Liabilities shows it stood at $20000.0 in 2022, then soared by 250.0% to $70000.0 in 2023, then soared by 170.36% to $189250.0 in 2024, then changed by 0.0% to $189250.0 in 2025.
- Per Business Quant, the three most recent readings for GWLL's Other Non-Current Liabilities are $189250.0 (Q3 2025), $189250.0 (Q2 2025), and $189250.0 (Q1 2025).